Botulinum Toxin Injection of the Vocal Fold for Spasmodic Dysphonia: A Preliminary Report
- 1 June 1987
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 113 (6) , 603-605
- https://doi.org/10.1001/archotol.1987.01860060029009
Abstract
• A number of different therapies have been used in the management of spasmodic dysphonia. None are curative, and the results of the most widely used surgical procedure (resection of the recurrent laryngeal nerve) are not universally good, with a high recurrence rate in some series. Furthermore, the procedure is not reversible. Using a special electromyographic hypodermic needle, we injected botulinum A toxin into one of the vocal folds of two patients with severe spasmodic dysphonia. Both had significant improvement without any complications. Although the resultant paresis is not permanent, the injection can be repeated as needed as an outpatient procedure. (Arch Otolaryngol Head Neck Surg 1987;113:603-605)This publication has 6 references indexed in Scilit:
- Botulinum A toxin for cranial‐cervical dystoniaNeurology, 1987
- Botulinum A Toxin Injection as a Treatment for BlepharospasmArchives of Ophthalmology (1950), 1985
- Neuropathology of spasmodic dysphoniaThe Laryngoscope, 1983
- Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patientsAnnals of Neurology, 1983
- Selective Section of the Recurrent Laryngeal Nerve for the Treatment of Spastic Dysphonia: An Experimental Study and Preliminary Clinical ReportOtolaryngology -- Head and Neck Surgery, 1981
- The Action of Botulinum Toxin at the Neuromuscular JunctionPublished by Defense Technical Information Center (DTIC) ,1980